Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO ISIN · CA46604F1099 LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2020-06-02 Regulatory Filings
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CFO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2020. It explicitly states it is a certification document and does not contain the actual interim financial statements or substantive financial data. The document length is short (3010 characters) and it serves as an officer certification rather than the interim report itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR).
2020-06-02 English
News release - English.pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CFO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2020. It is a certification letter related to interim filings, not the interim report itself. The document is short (3010 characters) and primarily an officer certification. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS), not as the interim report (IR).
2020-06-02 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is an announcement from Izotropic Corporation about the issuance of warrants under a warrant incentive program. It details the exercise of warrants, proceeds raised, and terms of the incentive warrants, including exercise price and hold period. There is no financial statement, quarterly or annual report data, or detailed financial analysis. The document is a corporate announcement related to capital raising activities through warrant issuance, which fits the category of Capital/Financing Update. The document length is 3213 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2020-05-27 English
News release - English.pdf
Regulatory Filings
2020-05-25 English
News release - English.pdf
Regulatory Filings
2020-05-20 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Izotropic Corporation has engaged StarFish Medical for the design and development of a commercial breast CT model. It contains no financial statements, regulatory form references, or detailed financial data. The content focuses on a business development update rather than financial results, governance, or regulatory filings. The document length is 4488 characters, which is relatively short and does not contain any indication of being an official report or filing. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement about a business development, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2020-05-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.